Repligen (RGEN) Other Operating Expenses (2010 - 2026)

Repligen (RGEN) has 17 years of Other Operating Expenses data on file, last reported at -$13.8 million in Q1 2026.

• On a quarterly basis, Other Operating Expenses changed N/A year-over-year to -$13.8 million in Q1 2026; TTM through Mar 2026 was $246.2 million, a 14.09% decrease from a year earlier, with the FY2025 full-year figure at $338.4 million, down 6.77% from the prior year.
• Other Operating Expenses for Q1 2026 stood at -$13.8 million, down from $92.6 million in the prior quarter.
• Over the last five years, Other Operating Expenses for RGEN reached as high as $131.9 million in Q4 2024 and fell as low as -$13.8 million in Q1 2026.
• Historically, Other Operating Expenses has averaged $78.1 million across 5 years, with a median of $80.5 million in 2022.
• Across the five-year window, Other Operating Expenses surged 48.48% in 2024 and slipped 29.82% in 2025, its largest moves.
• Year by year, Other Operating Expenses stood at $73.6 million in 2022, then rose by 20.74% to $88.8 million in 2023, then soared by 48.48% to $131.9 million in 2024, then fell by 29.82% to $92.6 million in 2025, then plunged by 114.87% to -$13.8 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were -$13.8 million in Q1 2026, $92.6 million in Q4 2025, and $84.1 million in Q3 2025.